Skip to content

New cervical cancer treatment approach could reduce risk of death by 40%, trial results show

A phase three UK trial found that a new approach to administering chemotherapy to cervical cancer patients improved survival risk. Researcher Dr. Mary McCormack and gynecologic oncologist Dr. Brian Slomovitz react to the findings. 

Read More

Back To Top